GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » Return-on-Tangible-Asset

Wright Medical Group NV (Wright Medical Group NV) Return-on-Tangible-Asset : -7.36% (As of Sep. 2020)


View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Wright Medical Group NV's annualized Net Income for the quarter that ended in Sep. 2020 was $-78.9 Mil. Wright Medical Group NV's average total tangible assets for the quarter that ended in Sep. 2020 was $1,071.3 Mil. Therefore, Wright Medical Group NV's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2020 was -7.36%.

The historical rank and industry rank for Wright Medical Group NV's Return-on-Tangible-Asset or its related term are showing as below:

WMGI' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -86.05   Med: -16.93   Max: -7.62
Current: -10.58

During the past 12 years, Wright Medical Group NV's highest Return-on-Tangible-Asset was -7.62%. The lowest was -86.05%. And the median was -16.93%.

WMGI's Return-on-Tangible-Asset is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -2.53 vs WMGI: -10.58

Wright Medical Group NV Return-on-Tangible-Asset Historical Data

The historical data trend for Wright Medical Group NV's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group NV Return-on-Tangible-Asset Chart

Wright Medical Group NV Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.68 -39.97 -18.66 -16.09 -10.34

Wright Medical Group NV Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.80 -6.23 -5.83 -23.36 -7.36

Competitive Comparison of Wright Medical Group NV's Return-on-Tangible-Asset

For the Medical Devices subindustry, Wright Medical Group NV's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wright Medical Group NV's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wright Medical Group NV's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Wright Medical Group NV's Return-on-Tangible-Asset falls into.



Wright Medical Group NV Return-on-Tangible-Asset Calculation

Wright Medical Group NV's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2019 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2019 )  (A: Dec. 2018 )(A: Dec. 2019 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2019 )  (A: Dec. 2018 )(A: Dec. 2019 )
=-114.225/( (1143.115+1067.291)/ 2 )
=-114.225/1105.203
=-10.34 %

Wright Medical Group NV's annualized Return-on-Tangible-Asset for the quarter that ended in Sep. 2020 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Sep. 2020 )  (Q: Jun. 2020 )(Q: Sep. 2020 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Sep. 2020 )  (Q: Jun. 2020 )(Q: Sep. 2020 )
=-78.888/( (1057.642+1084.909)/ 2 )
=-78.888/1071.2755
=-7.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2020) net income data.


Wright Medical Group NV  (NAS:WMGI) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Wright Medical Group NV Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Wright Medical Group NV's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Wright Medical Group NV (Wright Medical Group NV) Business Description

Traded in Other Exchanges
N/A
Address
Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB
Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.
Executives
Steven P. Wallace officer: President, International 1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan officer: SVP, Operations 1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith officer: SVP, Quality and Regulatory 1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper officer: SVP, Chief Digital Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier officer: President, Upper Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher officer: President, Lower Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter officer: SVP, Chief Compliance Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews officer: SVP, Global Finance 5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker officer: SVP, Process Improvement 5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton officer: SVP, Chief Human Resources Ofr 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry officer: EVP, Chief Finan./Op. Officer 5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey officer: SVP, Chief Comm. Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell officer: EVP, Chief Global Comm Officer C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano director, officer: President and Chief Executive 110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke officer: Pres. Emerging Markets AUS/JAP 5677 AIRLINE ROAD ARLINGTON TN 38002

Wright Medical Group NV (Wright Medical Group NV) Headlines

From GuruFocus

Keeley Asset Management Comments on Wright Medical Group

By Sydnee Gatewood Sydnee Gatewood 10-15-2019